Suven Pharmaceuticals Q1 Results

  • BSE: 543064
  • NSE: SUVENPHAR
  • ISIN: INE03QK01018
  • Sector: Biotechnology & Drugs
BSE
1,275.05-19.30 (-1.49%)
Volume18.75 K
Updated: Mon 25 Nov, 2024 | 15:29:44
NSE
1,293.9-1.25 (-0.10%)
Volume4.21 L
Updated: Mon 25 Nov, 2024 | 15:31:16
Today: 1,270.80
1,333.65
52-Wk: 578.05
1,358.75

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Suven Pharmaceuticals Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 24Mar 23QoQ CompJun 23YoY Comp
    Total Revenue 230.69369.36-%347.55-%
    Selling/ General/ Admin Expenses Total 45.6225.60-%28.74-%
    Depreciation/ Amortization 13.4011.96-%12.54-%
    Other Operating Expenses Total 14.4615.77-%16.21-%
    Total Operating Expense 164.16212.24-%193.13-%
    Operating Income 66.53157.12-%154.42-%
    Net Income Before Taxes 83.09166.21-%163.94-%
    Net Income 60.77123.97-%120.59-%
    Diluted Normalized EPS 2.394.87-%4.74-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts